Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1-29 March 1979
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1979
Report date:
1979

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Principles of method if other than guideline:
Instead of 5 rats/sex/group, 10 females/group were used.
GLP compliance:
no
Remarks:
did not exist at that time
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Chloroacetic acid
EC Number:
201-178-4
EC Name:
Chloroacetic acid
Cas Number:
79-11-8
Molecular formula:
C2H3ClO2
IUPAC Name:
chloroacetic acid
Details on test material:
- Name of test material (as cited in study report): Monochloressigsaure VM 2308

Test animals

Species:
rat
Strain:
Wistar
Sex:
female
Details on test animals or test system and environmental conditions:
no data

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 1%
MAXIMUM DOSE VOLUME APPLIED: max 16 ml/kg
Doses:
40 mg/kg
63 mg/kg
100 mg/kg
160 mg/kg
No. of animals per sex per dose:
10 females/dose
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: weekly weighing and no data on observation scheme
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, macroscopic examination
Statistics:
not applicable

Results and discussion

Effect levels
Sex:
female
Dose descriptor:
LD50
Effect level:
90.4 mg/kg bw
Based on:
test mat.
95% CL:
73.6 - 112
Mortality:
40 mg/kg 0/10
63 mg/kg 2/10
100 mg/kg 5/10
160 mg/kg 10/10
Clinical signs:
other: Animals which died during study: restless behaviour, uncoordinated movements, hunched posture, lethargy, lacrimation, piloerection, pulsing respiration. Surviving animals showed these symptoms at lower severity and recovered from all symptoms within 48 h
Gross pathology:
Surviving animals: no findings
Animals which died during the study showed red-brown and highly vascularised liver with patch pattern, red-pink lungs with foci. Spleen was black discolored at the stomach-side.

Applicant's summary and conclusion

Interpretation of results:
Category 3 based on GHS criteria
Conclusions:
Oral LD50= 90.4 mg/kg